MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Depreciation & Amortization (CF) of $3.1 million for Q4 2025, down 1.27% on a QoQ basis from $3.2 million in Q3 2025, and up 1.43% year-over-year from $3.1 million in Q4 2024.
MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $3.1 million for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 1.43% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.5 million (down 2.21% YoY) and the FY2025 annual result came in at $12.5 million, down 2.23% from the prior year.
- Depreciation & Amortization (CF) was $3.1 million for Q4 2025 at MeiraGTx Holdings, down from $3.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $3.9 million in Q4 2023 and bottomed at $1.8 million in Q1 2021.
- A 5-year average of $2.8 million and a median of $3.1 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 115.71% — and 2024, when it retreated 21.5%.
- MeiraGTx Holdings' Depreciation & Amortization (CF) stood at $2.1 million in 2021, then gained by 20.85% to $2.5 million in 2022, then soared by 56.98% to $3.9 million in 2023, then fell by 21.5% to $3.1 million in 2024, then advanced by 1.43% to $3.1 million in 2025.
- Business Quant data shows MGTX's Depreciation & Amortization (CF) at $3.1 million in Q4 2025, $3.2 million in Q3 2025, and $3.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.22 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Sep 30, 2023 | 3.48 Mn |